scispace - formally typeset
R

Rajkumar Banerjee

Researcher at Indian Institute of Chemical Technology

Publications -  94
Citations -  7364

Rajkumar Banerjee is an academic researcher from Indian Institute of Chemical Technology. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 24, co-authored 80 publications receiving 6592 citations. Previous affiliations of Rajkumar Banerjee include University of Pittsburgh & Academy of Scientific and Innovative Research.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells.

Rajkumar Banerjee, +3 more
- 20 Nov 2004 - 
TL;DR: The present study is the first to demonstrate the use of small molecular weight ligand for mediating efficient targeting of liposomal drugs to sigma receptor expressing prostate cancer cells both in vitro and in vivo.
Journal ArticleDOI

The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor.

Debojit Bose, +7 more
- 23 Jan 2012 - 
TL;DR: It is suggested that Streptomycin down-regulates miR-21 by binding to pre-miRNA (its precursor) and blocking the function of the Dicer enzyme, an essential step in miRNA maturation.
Journal ArticleDOI

Green Synthesis and Characterization of Monodispersed Gold Nanoparticles: Toxicity Study, Delivery of Doxorubicin and Its Bio-Distribution in Mouse Model.

Sudip Mukherjee, +7 more
- 01 Jan 2016 - 
TL;DR: The results demonstrate that a biosynthesized gold nanoparticle-based drug-delivery system (b-Au-PP-Dox) could be used in the near future as an alternative cost-effective treatment strategy for cancer therapy.
Journal ArticleDOI

Novel series of non-glycerol-based cationic transfection lipids for use in liposomal gene delivery.

Rajkumar Banerjee, +4 more
- 01 Oct 1999 - 
TL;DR: The results reemphasize the important point that in cationic lipid-mediated gene delivery, the overall charge of the lipid-DNA complex need not always be positive and imply that favorable hydrogen-bonding interactions between the lipid headgroups and the cell surface of biological membranes may have some role for improved transfection efficiency.